Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Those who have close contact with patients with novel coronavirus pneumonia; 2) Be over 18 years old (including 18 years old); 3) Voluntarily sign written informed consent.
Exclusion criteria
Exclusion criteria: 1) According to the researcher's judgment, the diseases that have been or have suffered may affect the patients to participate in the trial; 2) Those who are allergic to the known ingredients of this medicine; 3) Pregnant or lactating women; 4) Patients who have participated in other clinical trials in the past 3 months; 5) The researcher believes that there is anything unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compared with the control group, the positive rate of NCP nucleic acid test on subjects used Compound Houttuynia Mixture.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Compared with the control group, the time for NCP nucleic acid test results to change to positive of subjects used Compound Houttuynia Mixture.;Compared with the control group, the proportion of mild and severe subjects whose NCP nucleic acid test results to change to positive used Compound Houttuynia Mixture.;Compared with the control group, the proportion of subjects with different severity of main clinical symptoms (fever, fatigue, dry cough) whose NCP nucleic acid test results to change to positive used Compound Houttuynia Mixture.;Compared with the control group, the time for NCP nucleic acid test results to change from positive to negative of NCP subjects used Compound Houttuynia Mixture.; | — |
Countries
China
Contacts
Public ContactDawei Wang
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
Outcome results
None listed